Pulmonary Arterial Hypertension

The AJMC® Pulmonary Arterial Hypertension compendium is a comprehensive resource for clinical news and expert insights for the progressive disorder, which is characterized by high blood pressure in the arteries that go from the heart to the lungs.

Latest News

Doctor holds lung model representing PAH | Image Credit: © Orawan - stock.adobe.com
Certain Immune Cells May Increase, Decrease PAH Risk

October 16th 2024

Using Mendelian randomization analysis, researchers found evidence that 2 small groups of immunophenotypes are linked to either greater or lesser odds of developing pulmonary arterial hypertension (PAH).

Mobility reduction may be an early sign of PAH | image credit: PrusarooYakk - stock.adobe.com
A Call for Consistent Digital Mobility Measurement Protocols in PAH

October 9th 2024

Carboard cutout of lungs with a stethoscope and the words Pulmonary Hypertension | Image credit: Dzmitry - stock.adobe.com
Complementary Therapies Improve Quality of Life in PH

October 4th 2024

Human lungs on scientific background | Image Credit: © Crystal light - stock.adobe.com
Combined Chemotherapy and Immunotherapy Improves Outcomes in PAH

September 27th 2024

Man holding paper model of lungs | Image credit: Elena - stock.adobe.com
Comorbidities Require Special Treatment Consideration for PAH

September 20th 2024

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo